Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Enfermedad de Alzheimer y Demencias

8233 ARTÍCULOS , VIENDO DEL 7771 AL 7785

Promising Natural Remedies for Alzheimer's Disease Therapy

Thawabteh AM, Ghanem AW, AbuMadi S, Thaher D, Jaghama W, Karaman D, Karaman R.

Molecules. 2025 Feb 17;30(4):922. doi: 10.3390/molecules30040922.

Unveiling the mTOR pathway modulation by SGLT2 inhibitors: a novel approach to Alzheimer's disease in type 2 diabetes

Ramakrishan P, Rajangam J, Mahinoor SS, Bisht S, Mekala S, Upadhyay DK, Solomon VR, Sabarees G, Pelluri R.

Metab Brain Dis. 2025 Feb 26;40(3):132. doi: 10.1007/s11011-025-01555-4.

Unlocking the therapeutic promise of miRNAs in promoting amyloid-β clearance for Alzheimer's disease

Kaur V, Sunkaria A.

Behav Brain Res. 2025 Apr 27;484:115505. doi: 10.1016/j.bbr.2025.115505. Epub 2025 Feb 25.

The Potential Mechanism and the Role of Antioxidants in Mitigating Oxidative Stress in Alzheimer's Disease

Naik RA, Mir MN, Malik IA, Bhardwaj R, Alshabrmi FM, Mahmoud MA, Alhomrani M, Alamri AS, Alsanie WF, Hjazi A, Ghatak T, Poeggeler B, Singh MP, Ts G, Singh SK.

Front Biosci (Landmark Ed). 2025 Feb 18;30(2):25551. doi: 10.31083/FBL25551.

Decrypting the Possible Mechanistic Role of Fenofibrate in Alzheimer's Disease and Type 2 Diabetes: The Truth and Mystery

Alsaleem MA, Al-Kuraishy HM, Al-Gareeb AI, Abdel-Fattah MM, Alrouji M, Al-Harchan NA, Alruwaili M, Papadakis M, Alexiou A, Batiha GE.

J Cell Mol Med. 2025 Mar;29(5):e70378. doi: 10.1111/jcmm.70378.

[Neurobiological potential of astragaloside IV and prospects for its use in the treatment of Alzheimer's disease]

Berezutsky MA, Durnova NA, Kurchatova MN, Matvienko UA.

Zh Nevrol Psikhiatr Im S S Korsakova. 2025;125(2):7-12. doi: 10.17116/jnevro20251250217.

Safety and effectiveness of the anti-amyloid monoclonal antibody (mAb) drug lecanemab for early Alzheimer's disease: The pharmacovigilance perspective

Bobbins A, Davies M, Lynn E, Roy D, Yeomans A, Shakir SAW.

Br J Clin Pharmacol. 2025 May;91(5):1352-1360. doi: 10.1002/bcp.70021. Epub 2025 Mar 6.

Bioactive peptides as multipotent molecules bespoke and designed for Alzheimer's disease

Mesias A, Borges S, Pintado M, Baptista-Silva S.

Neuropeptides. 2025 Jun;111:102515. doi: 10.1016/j.npep.2025.102515. Epub 2025 Mar 4.

Insulin resistance in Alzheimer's disease: signalling mechanisms and therapeutics strategies

Dahiya M, Yadav M, Goyal C, Kumar A.

Inflammopharmacology. 2025 Apr;33(4):1817-1831. doi: 10.1007/s10787-025-01704-2. Epub 2025 Mar 10.

Going beyond ATP binding site as a novel inhibitor design strategy for tau protein kinases in the treatment of Alzheimer's disease: A review

Zaater MA, El Kerdawy AM, Mahmoud WR, Abou-Seri SM.

Int J Biol Macromol. 2025 May;307(Pt 3):142141. doi: 10.1016/j.ijbiomac.2025.142141. Epub 2025 Mar 14.

GSK-3β dysregulation in aging: Implications for tau pathology and Alzheimer's disease progression

Rekha A, Afzal M, Babu MA, Menon SV, Nathiya D, Supriya S, Mishra SB, Gupta S, Goyal K, Rana M, Ali H, Imran M.

Mol Cell Neurosci. 2025 Jun;133:104005. doi: 10.1016/j.mcn.2025.104005. Epub 2025 Mar 20.

CaMKII mechanisms that promote pathological LTP impairments

Larsen ME, Rumian NL, Quillinan N, Bayer KU.

Curr Opin Neurobiol. 2025 Jun;92:102961. doi: 10.1016/j.conb.2024.102961. Epub 2025 Mar 31.

Ferroptosis and Alzheimer's: unveiling new avenues for the treatment and prevention

Sharma V, Sharma P, Singh TG.

Metab Brain Dis. 2025 Apr 1;40(4):167. doi: 10.1007/s11011-025-01587-w.

The endocannabinoid system offers a target for Alzheimer's disease treatment through inhibition of fatty acid amide hydrolase (FAAH)

de Ceballos ML.

FEBS J. 2025 Aug;292(16):4156-4159. doi: 10.1111/febs.70082. Epub 2025 Apr 2.

Therapeutic modulation of neurogenesis to improve hippocampal plasticity and cognition in aging and Alzheimer's disease

Mostafa M, Disouky A, Lazarov O.

Neurotherapeutics. 2025 Apr;22(3):e00580. doi: 10.1016/j.neurot.2025.e00580. Epub 2025 Apr 2.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias